-
公开(公告)号：US20230364021A1
公开(公告)日：2023-11-16
申请号：US18354293
申请日：2023-07-18
Applicant: CRITITECH, INC.
Inventor： Jacob SITTENAUER , Joseph FARTHING , Mark WILLIAMS , Michael BALTEZOR , Gere DIZEREGA , Aranza Barreda ABARCA , Shelby CLARK
Abstract: Particles of at least 95% by weight of sorafenib, or a pharmaceutically acceptable salt thereof are provided, wherein the particles have a specific surface area (SSA) of at least 2 m2/g and have a mean particle size by volume distribution of between about 0.7 μm and about 8 μm, as are methods for their use, and methods for making such particles.
-
公开(公告)号：US20220241257A1
公开(公告)日：2022-08-04
申请号：US17381705
申请日：2021-07-21
Applicant: CRITITECH, INC.
Inventor： Jacob SITTENAUER , Joseph FARTHING , Mark WILLIAMS , Michael BALTEZOR , Gere DIZEREGA , Aranza Barreda ABARCA , Shelby CLARK
Abstract: The disclosure provides particles of at least 95% by weight of sorafenib, or a pharmaceutically acceptable salt thereof, wherein the particles have a specific surface area (SSA) of at least 2 m2/g and have a mean particle size by volume distribution of between about 0.7 μm and about 8 μm, methods for their use, and methods for making such particles.
-
公开(公告)号：US20210387961A1
公开(公告)日：2021-12-16
申请号：US17401654
申请日：2021-08-13
Applicant: CRITITECH, INC.
Inventor： Mark WILLIAMS , Jacob SITTENAUER , Shelby CLARK , Joseph FARTHING , Michael BALTEZOR , Matthew MCCLOREY
IPC: C07D401/10 , A61P31/04 , A61K9/14 , A61K9/00
Abstract: The present disclosure relates to ciprofloxacin polymorphs and their use in treating infections.
-
公开(公告)号：US20240226116A1
公开(公告)日：2024-07-11
申请号：US18608226
申请日：2024-03-18
Applicant: CRITITECH, INC.
Inventor： Michael BALTEZOR , Matthew MCCLOREY , Joseph S. FARTHING , Mark WILLIAMS , Jacob SITTENAUER
IPC: A61K31/569 , A61K9/00 , A61K9/16 , A61K31/496 , A61P9/00
CPC classification number: A61K31/569 , A61K9/0075 , A61K9/1688 , A61K31/496 , A61P9/00
Abstract: Disclosed herein are particles of at least 95% by weight of a glucocorticoid that have a specific surface area of at least 10 m2/g, methods for making, such particles, and methods for their use as therapeutics. Also disclosed herein are particles of at least 95% by weight of an indolinone that have a specific surface area of at least 10 m2/g, methods for making such particles, and methods for-their use as therapeutics.
-
公开(公告)号：US20240216424A1
公开(公告)日：2024-07-04
申请号：US18556705
申请日：2022-04-25
Applicant: CRITITECH, INC.
Inventor： Jacob SITTENAUER , Aranza Barreda ABARCA , Joseph FARTHING , Mark WILLIAMS , Michael BALTEZOR
IPC: A61K33/243 , A61K9/12 , A61K9/16 , A61P31/00
CPC classification number: A61K33/243 , A61K9/12 , A61K9/1629 , A61P31/00
Abstract: Compositions of particles having at least 95% by weight of cisplatin and a specific surface area (8SA) of at least 3.5 m2/g. methods for their use. and methods for their production are provided.
-
Patent Agency Ranking
公开(公告)号：US20230142591A1
公开(公告)日：2023-05-11
申请号：US18053491
申请日：2022-11-08
Applicant: CRITITECH, INC.
Inventor： Jacob SITTENAUER , Aranza Barreda ABARCA , Shelby CLARK , Joseph FARTHING , Mark WILLIAMS , Gere DIZEREGA , Michael BALTEZOR
IPC: A61K31/454 , A61K9/00 , A61K9/16
CPC classification number: A61K31/454 , A61K9/008 , A61K9/1688
Abstract: Compositions of particles having at least 95% by weight of niraparib and a specific surface area (SSA) of at least 5 m2/g, methods for their use, and methods for their production are provided.
-
公开(公告)号：US20230414510A1
公开(公告)日：2023-12-28
申请号：US18042930
申请日：2021-09-08
Applicant: CRITITECH, INC.
Inventor： Michael BALTEZOR , Jacob SITTENAUER , Joseph FARTHING , Mark WILLIAMS , Aranza Barreda ABARCA
IPC: A61K9/14 , A61K31/167 , A61K47/18 , A61K9/16
CPC classification number: A61K9/145 , A61K9/1694 , A61K47/18 , A61K31/167
Abstract: The disclosure provides compositions and methods for use of compositions that include particles comprising at least 30% niclosamide by weight, or a pharmaceutically acceptable salt, hydrate, or solvate thereof, wherein the particles have one or more of: (i) a mean bulk density (not tapped) of less than 0.40 g/cm3; 00 a mean tapped density of less than 0.55 g/cm 3 ; and/or (in) a specific surface area (SSA) of at least 3.6 m2/g.
-
公开(公告)号：US20220370355A1
公开(公告)日：2022-11-24
申请号：US17812479
申请日：2022-07-14
Applicant: CRITITECH, INC.
Inventor： Jacob SITTENAUER , Joseph FARTHING , Mark WILLIAMS , Michael BALTEZOR , Gere DIZEREGA , Aranza Barreda ABARCA , Shelby CLARK
IPC: A61K9/14 , A61K31/5365 , A61K47/26
Abstract: The disclosure provides particles of at least 95% by weight of lapatinib, or a pharmaceutically acceptable salt thereof, wherein the particles have a specific surface area (SSA) of at least 10 m2/g and have a mean particle size by volume distribution of between about 0.7 μm and about 8 μm.
-
公开(公告)号：US20220023215A1
公开(公告)日：2022-01-27
申请号：US17381786
申请日：2021-07-21
Applicant: CRITITECH, INC.
Inventor： Jacob SITTENAUER , Joseph FARTHING , Mark WILLIAMS , Michael BALTEZOR , Gere DIZEREGA , Aranza Barreda ABARCA , Shelby CLARK
IPC: A61K9/14 , A61K31/5365 , A61K47/26
Abstract: The disclosure provides particles of at least 95% by weight of lapatinib, or a pharmaceutically acceptable salt thereof, wherein the particles have a specific surface area (SSA) of at least 10 m2/g and have a mean particle size by volume distribution of between about 0.7 μm and about 8 μm.
-
公开(公告)号：US20230142186A1
公开(公告)日：2023-05-11
申请号：US18053557
申请日：2022-11-08
Applicant: CRITITECH, INC.
Inventor： Jacob SITTENAUER , Aranza Barreda ABARCA , Shelby CLARK , Joseph FARTHING , Mark WILLIAMS , Gere DIZEREGA , Michael BALTEZOR
CPC classification number: A61K31/55 , A61K9/1688 , A61K9/16
Abstract: Compositions of particles having at least 95% by weight of rucaparib and a specific surface area (SSA) of at least 12 m2/g, methods for their use, and methods for their production are provided.
-
-
-
-
-
-
-
-
-
Search Results
12
records
(took 0.015 seconds)
